Because higher insulin levels are indicative of metabolic syndrome and both have previously been associated with increased risk of developing and dying from prostate cancer, we initially predicted that higher insulin levels would also correlate with shorter time to castration-resistant progression. The gene discussed is INS; the disease is prostate carcinoma.